← All trials
NCT05161637
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2023
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- Dec 17, 2021
- Last posted
- Jul 8, 2022
- Enrollment
- 415
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Taiwan Liposome CompanyLead sponsor
- Taiwan Liposome CompanyStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.